Leap Therapeutics Inc (LPTX)
2.88
-0.12
(-3.84%)
USD |
NASDAQ |
Nov 14, 16:00
2.95
+0.07
(+2.43%)
After-Hours: 20:00
Leap Therapeutics Enterprise Value: 36.12M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 36.12M |
| November 12, 2024 | 45.88M |
| November 11, 2024 | 46.65M |
| November 08, 2024 | 45.50M |
| November 07, 2024 | 54.30M |
| November 06, 2024 | 63.48M |
| November 05, 2024 | 57.36M |
| November 04, 2024 | 61.95M |
| November 01, 2024 | 64.63M |
| October 31, 2024 | 64.63M |
| October 30, 2024 | 81.08M |
| October 29, 2024 | 97.92M |
| October 28, 2024 | 80.32M |
| October 25, 2024 | 59.27M |
| October 24, 2024 | 47.41M |
| October 23, 2024 | 38.61M |
| October 22, 2024 | 37.85M |
| October 21, 2024 | 35.55M |
| October 18, 2024 | 23.88M |
| October 17, 2024 | 10.68M |
| October 16, 2024 | 13.36M |
| October 15, 2024 | 9.147M |
| October 14, 2024 | 11.06M |
| October 11, 2024 | 9.912M |
| October 10, 2024 | 10.68M |
| Date | Value |
|---|---|
| October 09, 2024 | 11.83M |
| October 08, 2024 | 13.36M |
| October 07, 2024 | 12.59M |
| October 04, 2024 | 19.48M |
| October 03, 2024 | 16.03M |
| October 02, 2024 | 15.27M |
| October 01, 2024 | 13.74M |
| September 30, 2024 | 19.86M |
| September 27, 2024 | 24.84M |
| September 26, 2024 | 22.16M |
| September 25, 2024 | 21.39M |
| September 24, 2024 | 20.63M |
| September 23, 2024 | 25.22M |
| September 20, 2024 | 27.51M |
| September 19, 2024 | 30.19M |
| September 18, 2024 | 31.72M |
| September 17, 2024 | 28.66M |
| September 16, 2024 | 36.70M |
| September 13, 2024 | 26.37M |
| September 12, 2024 | 29.04M |
| September 11, 2024 | 27.51M |
| September 10, 2024 | 29.50M |
| September 09, 2024 | 29.43M |
| September 06, 2024 | 29.04M |
| September 05, 2024 | 33.25M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-66.21M
Minimum
Apr 11 2023
275.84M
Maximum
Sep 24 2021
32.04M
Average
35.38M
Median
May 30 2024
Enterprise Value Benchmarks
| AIM ImmunoTech Inc | 7.900M |
| Perspective Therapeutics Inc | 378.39M |
| Protalix BioTherapeutics Inc | 66.58M |
| Electromed Inc | 224.00M |
| Armata Pharmaceuticals Inc | 183.40M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -20.13M |
| Total Expenses (Quarterly) | 21.00M |
| EPS Diluted (Quarterly) | -0.52 |
| Earnings Yield | -60.42% |
| Normalized Earnings Yield | -164.93 |